Institut Catala d Oncologia Hospitalet Hospital Duran i Reynals

Barcelona 08908

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Castration-resistant Prostate Cancer

Studies at this site

• Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute) — Running, not enrolling